Synthace logo — Helping scientists solve the world's most pressing problems...

Synthace

Helping scientists solve the world's most pressing problems with faster, more powerful experiments.

Founded 2011 United Kingdom London, United Kingdom 36 employees Series C Total: $75.00M Automation, Biotechnology +2

General Information

Company Name Synthace
Founded Year 2011
Location United Kingdom London, United Kingdom
Employees 36
Industries Automation, Biotechnology, Life Sciences +1
Funding Stage Series C
Business Model SaaS, B2B, Platform
Revenue Model Subscription, Service Fee, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Synthace. To contact Synthace, visit synthace.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Synthace compare?

A PDF of Synthace and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Synthace soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Synthace

Synthace, established in 2011 and headquartered in the United Kingdom, is making significant strides in the biotech industry with its advanced software solutions. Positioned within the Automation, Biotechnology, Life Sciences, and Pharmaceutical sectors, Synthace offers an innovative, end-to-end software platform designed to empower scientists. Their tools facilitate the design, automation, and analysis of complex experiments, streamlining processes to derive faster and more meaningful biological insights.

The company's mission, encapsulated in their slogan—"Helping scientists solve the world's most pressing problems with faster, more powerful experiments."—speaks to their commitment to elevating scientific research.

Their latest funding round, a $35.00M Series C investment in November 2021, was backed by prominent investors such as SOSV, Sofinnova Partners, and Horizons Ventures. This financial backing highlights the confidence investors have in Synthace's potential to revolutionize life sciences research.

Business keywords: Digital Experiment Platform, Life Science R&D, Lab Automation, Biological Insight, Multifactorial Experiments, Data Structuring, Experiment Simulation, Reproducible Experiments, Automation Equipment, Metadata Management, Browser-Based Control, Code-Free Operation, Scientific Value Enhancement, Complex Experimentation

Services & Products

Automated multivariate experiments
Assay development
Media optimization
Miniaturized purification
Software for high dimensional data analysis
On-site support and training

Target Customers

Pharmaceutical companies Biotechnology firms Research and development teams Academia Biotechnology startups

Funding Rounds & Investors (13)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $35.00M 3
SOSV, Sofinnova Partners +1
16 Nov 2021
Convertible Note Undisclosed 1
SOSV
31 Mar 2021
Venture Round Undisclosed 1
SOSV
13 Feb 2020
Series B $25.60M 3
SOSV, Horizons Ventures +1
12 Dec 2018
Series A Undisclosed 2
SOSV, Future Planet Capital
23 May 2018
Series A £7.30M 8
SOSV, 11.2 Capital +6
19 Sep 2017
Convertible Note Undisclosed 1
Future Planet Capital
01 Dec 2016
Venture Round Undisclosed 1
Upscale
26 Jan 2016
Venture Round £2.20M 3
Sofinnova Partners, UK Innovation & Science Seed Fund +1
11 Feb 2015
Series A £2.20M 4
SOSV, UK Innovation & Science Seed Fund +2
05 Dec 2014

View All 13 Funding Rounds

Synthace Alternatives & Competitors

View All Alternatives
Synthace vs
Strateos
Strateos United States

Strateos is a pioneer in the development of remote access laboratories and lab control software for...

Series B
27 employees
Automation, Biotechnology
Synthace vs
PostEra
PostEra United States

Medicinal Chemistry powered by Machine Learning

Series A
43 employees
AI, Biotechnology
Synthace vs
Automata
Automata United Kingdom

Where legacy ends, Automata begins.

Series C
167 employees
AI, Biotechnology

FAQ About Synthace

Helping scientists solve the world's most pressing problems with faster, more powerful experiments.
Synthace was founded in 2011.
Synthace is headquartered in London, United Kingdom.
Synthace operates in Automation, Biotechnology, Life Sciences and Pharmaceutical. Its work centres on Digital Experiment Platform, Life Science R&D, Lab Automation and Biological Insight. Its customers include Pharmaceutical companies, Biotechnology firms and Research and development teams.
Synthace has a SaaS, B2B and Platform business model. Its revenue comes from Subscription, Service Fee and Usage Based.
Synthace has approximately 36 employees.
Synthace has completed 13 funding rounds, raising a total of $75.00M. The latest funding stage is Series C.
Synthace offers: Automated multivariate experiments, Assay development, Media optimization, Miniaturized purification, Software for high dimensional data analysis, On-site support and training.
Top alternatives and competitors to Synthace include Strateos, PostEra, Automata, AnaBios Corporation, deepmirror. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Synthace and Strateos are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Synthace, https://bouncewatch.com/company/synthace, updated 2 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes